Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Drug Metab. 2013 Mar;14(3):361-5.

Xenobiotic sulphation and its variability during inflammation: a factor in adverse drug reactions?

Author information

  • 1Centre for Toxicology, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK. R.H.WARING@bham.ac.uk

Abstract

The interactions between disease processes and the metabolism of therapeutic drugs have not been systematically investigated. Inflammation, with the presence of pro-inflammatory cytokines, affects Phase 1 metabolism, particularly the activity of the CYP isoforms. Inflammatory factors also alter the activity of some Phase 2 enzymes, particularly the sulphotransferases (SULT isoforms) responsible for drug sulphonation and the enzyme pathway involved in the supply of sulphate for this reaction. Being ill may, therefore, in itself make drug metabolism unpredictable.

PMID:
23176089
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Write to the Help Desk